Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma
Male
0301 basic medicine
QH426-470
HNSCC
03 medical and health sciences
lncRNA
Genetics
Biomarkers, Tumor
Tumor Microenvironment
Humans
Gene Regulatory Networks
Internal medicine
Squamous Cell Carcinoma of Head and Neck
Computational Biology
Middle Aged
Prognosis
RC31-1245
3. Good health
Immune
Gene Expression Regulation, Neoplastic
Survival Rate
MicroRNAs
Tumor microenvironment
Head and Neck Neoplasms
Female
RNA, Long Noncoding
Gene expression
Transcriptome
Research Article
DOI:
10.1186/s12920-020-0707-0
Publication Date:
2020-03-30T11:03:04Z
AUTHORS (11)
ABSTRACT
Abstract Background As the sixth most common cancer worldwide, head and neck squamous cell carcinoma (HNSCC) develops visceral metastases during advanced stage of disease exhibits a low five-year survival rate. The importance tumor microenvironment (TME) in initiation metastasis is widely recognized. In addition, accumulating evidence indicates that long non-coding RNA (lncRNA) involved crosstalk between TME cells. However, lncRNA-associated regulators modulating HNSCC progression remain largely unknown. Methods publicly available transcriptome data matched clinical were collected from Cancer Genome Atlas (TCGA). Immune scores (ISs) stromal (SSs) calculated using ESTIMATE algorithm. Weighted gene co-expression network analysis (WGCNA) was conducted to determine co-expressed lncRNAs protein-coding mRNAs. Results showed high IS male patient subgroup exhibited improved survival. Additionally, we identified 169 825 mRNAs differentially expressed samples, with up-regulated displaying enrichment immune-related biological processes. Notably, lncRNA-mRNA module (i.e., purple module) strong correlation ISs. This contained 79 442 mRNAs, including 26 215 showing association expression Consistently, 207 group enriched signaling pathways. Based on bioinformatics analyses previous functional assays, certain (e.g., AL365361.1 PCED1B-AS1 ) likely contributed modification immune (TIME) patients, achieved by regulating transcription abundant genes CCR7 TLR8 ). Conclusions summary, ascertained displayed ISs good probability. We hundreds specific patterns this as well highly great potential for modulation TIME HNSCC. Our study provides link network, TIME, progression, highlights therapeutic targets disease.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (50)
CITATIONS (22)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....